ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1382

The 11q23.3 Genomic Region – rs964184- Is Associated With Cardiovascular Disease In Patients With Rheumatoid Arthritis

Raquel lopez Mejias1, Fernanda Genre2, Mercedes García-Bermúdez3, Santos Castañeda4, Carlos González-Juanatey5, J. Llorca6, Encarnación Amigo7, Alfonso Corrales8, Jose A. Miranda-Filloy9, Javier Rueda-Gotor1, Carmen Gomez vaquero10, Luis Rodriguez Rodriguez11, Benjamin Fernandez Gutierrez11, Alejandro Balsa12, Dora Pascual-Salcedo13, Francisco Javier López-Longo14, Patricia Carreira15, Ricardo Blanco1, Isidoro González-Alvaro16, Javier Martin17 and Miguel A. Gonzalez-Gay18, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IFIMAV, Santander, Spain., Santander, Spain, 2Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, 3Immunology and Cellular Biology, Instituto de Parasitologia y Biomedicina López-Neyra, IPBLN-CSIC, Granada, Spain, 4Rheumatology, Hospital Universitario de La Princesa, IIS Princesa, Madrid, Spain, 5Cardiology Division, Hospital Lucus Augusti, Lugo, Spain, 6Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 7Hospital Universitario Lucus Augusti, Rheumatology Division, Lugo, Spain, 8Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Spain, Santander, Spain, 9Rheumatology, Division of Rheumatology, Hospital Lucus Augusti, Lugo, Spain, 10Department of Rheumatology, Hospital Universitario Bellvitge, Barcelona, Spain, 11Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 12Rheumatology unit, La Paz University Hospital, Rheumatology, Madrid, Spain, 13La Paz University Hospital, Rheumatology, Madrid, Spain, 14Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, 15Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 16Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 17Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN-CSIC), Granada, Spain, 18Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IFIMAV, Santander, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis and high risk of cardiovascular (CV) disease. A recent meta-analysis has described the rs964184 polymorphism as one of the most important signals associated with coronary artery disease, increased LDL-cholesterol and decreased HDL-cholesterol levels in non-rheumatic Caucasian individuals. In the present study we assessed the potential association of this gene polymorphism with CV disease in RA.

Methods:

2160 Spanish patients with RA were genotyped for the rs964184 polymorphism. Three hundred and eighty-four (17.7%) of them had experienced CV events. The rs964184 polymorphism was genotyped with TaqMan single-nucleotide polymorphism (SNP) genotyping assays (C___8907629_10) in a 7900 HT real-time polymerase chain reaction (PCR) system

Results:

Sex (men), age at RA diagnosis and most traditional CV risk factors (diabetes mellitus, dyslipidemia and smoking habit) were associated with increased risk of CV events (p<0.05 in all the cases). Interestingly, when RA patients were stratified according to the presence or absence of CV disease after adjusting for sex, age at RA diagnosis, and traditional CV risk factors, we observed that RA patients carrying the rs964184 GG genotype had significantly higher risk of CV events than those with CC genotype (HR = 2.91, 95% CI: 1.36 – 6.26, p = 0.006).

Conclusion:

Our results indicate that rs964184 polymorphism is associated with CV disease in RA.


Disclosure:

R. lopez Mejias,
None;

F. Genre,
None;

M. García-Bermúdez,
None;

S. Castañeda,
None;

C. González-Juanatey,
None;

J. Llorca,
None;

E. Amigo,
None;

A. Corrales,
None;

J. A. Miranda-Filloy,
None;

J. Rueda-Gotor,
None;

C. Gomez vaquero,
None;

L. Rodriguez Rodriguez,
None;

B. Fernandez Gutierrez,
None;

A. Balsa,
None;

D. Pascual-Salcedo,
None;

F. J. López-Longo,
None;

P. Carreira,
None;

R. Blanco,
None;

I. González-Alvaro,
None;

J. Martin,
None;

M. A. Gonzalez-Gay,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-11q23-3-genomic-region-rs964184-is-associated-with-cardiovascular-disease-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology